Cabaletta Bio, Inc. Quarterly report [Sections 13 or 15(d)]

Leases (Tables)

3 Months Ended

Mar. 31, 2026

The following table contains information pertaining to the Company’s operating and finance leases for the three months ended March 31, 2026 and 2025.


	Three Months Ended March 31,
	2026			2025
Cash paid in the measurement of lease liabilities
Operating cash flows used for operating leases	$	1,057		$	1,057
Operating cash flows used for finance leases		877			208
Financing cash flows for finance leases		4,271			552
Other information
Weighted average remaining lease term - finance leases (in years)		1.2			1.5
Weighted average discount rate - finance leases		10.2	%		11.0	%
Weighted average remaining lease term - operating leases (in years)		0.7			1.4
Weighted average discount rate - operating leases		10.3	%		11.0	%

Future lease payments under the non-cancelable leases as of March 31, 2026 are as follows:


	Finance Leases			Operating Leases
2026	$	17,568		$	2,576
2027		7,950			—
Total undiscounted lease payments		25,518			2,576
Less imputed interest		(1,553	)		(91	)
Total lease liability	$	23,965		$	2,485